Venturi Wealth Management LLC increased its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 12.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,725 shares of the technology company’s stock after purchasing an additional 1,305 shares during the period. Venturi Wealth Management LLC’s holdings in Amdocs were worth $1,026,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the stock. Crossmark Global Holdings Inc. boosted its stake in shares of Amdocs by 34.7% during the third quarter. Crossmark Global Holdings Inc. now owns 145,556 shares of the technology company’s stock valued at $12,733,000 after purchasing an additional 37,516 shares during the period. Covestor Ltd raised its position in shares of Amdocs by 48.4% in the 3rd quarter. Covestor Ltd now owns 2,987 shares of the technology company’s stock worth $261,000 after purchasing an additional 974 shares during the last quarter. Atria Investments Inc raised its position in Amdocs by 7.2% in the 3rd quarter. Atria Investments Inc now owns 9,408 shares of the technology company’s stock worth $823,000 after buying an additional 634 shares during the last quarter. Verdence Capital Advisors LLC raised its position in Amdocs by 5.6% in the 3rd quarter. Verdence Capital Advisors LLC now owns 4,375 shares of the technology company’s stock worth $383,000 after buying an additional 232 shares during the last quarter. Finally, Executive Wealth Management LLC raised its position in Amdocs by 14.2% in the 3rd quarter. Executive Wealth Management LLC now owns 84,106 shares of the technology company’s stock worth $7,358,000 after buying an additional 10,466 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on DOX. Stifel Nicolaus began coverage on Amdocs in a research note on Wednesday, October 2nd. They set a “buy” rating and a $100.00 price target for the company. StockNews.com upgraded Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, October 25th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $102.00.
Amdocs Price Performance
Shares of DOX stock opened at $92.86 on Tuesday. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04. The stock’s 50-day moving average is $87.92 and its 200 day moving average is $83.81. The company has a market cap of $10.91 billion, a P/E ratio of 21.40, a PEG ratio of 1.49 and a beta of 0.74. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.24 and a quick ratio of 1.24.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
- Five stocks we like better than Amdocs
- Differences Between Momentum Investing and Long Term Investing
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What is the Hang Seng index?
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- What is a SEC Filing?
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.